DPT

CanSinoBIO CSO Shares the Latest Results of the Company's Globally Innovative Pneumococcal Vaccine

Retrieved on: 
Freitag, April 26, 2024
Tao, Vaccination, Public, Pneumonia, DPT, Conference, Vaccine, CanSino Biologics, Shingles, ACFM, Meningitis, CSO, Streptococcus pneumoniae, CPMA, Tuberculosis, Attenuated vaccine, Ageing

Dr. Tao Zhu, Chief Scientific Officer (CSO) of CanSino Biologics Inc. (CanSinoBIO), was invited to give a presentation at the conference.

Key Points: 
  • Dr. Tao Zhu, Chief Scientific Officer (CSO) of CanSino Biologics Inc. (CanSinoBIO), was invited to give a presentation at the conference.
  • Dr. Zhu introduced the latest progress and breakthrough made in the development of pneumococcal vaccines both in China and abroad, focusing on sharing the latest results from the clinical trials of the company's globally innovative protein-based pneumococcal vaccine (PBPV).
  • Positive results have been obtained from Phase I clinical trials of the PBPV.
  • The company is committed to developing pneumococcal vaccines, especially higher-valency serotype vaccines to improve the effectiveness of vaccines.

Speaker and Award Nominations Open for 2024 Ascend Rehab Therapy Business Summit

Retrieved on: 
Donnerstag, Mai 2, 2024
ATC, Marketing, PXM, DPT, Practice, Management

PHOENIX, May 2, 2024 /PRNewswire/ -- WebPT, the leading rehab therapy platform for Practice Experience Management (PXM), today announces the call for speaker proposals and award nominations for Ascend 2024, taking place in Chicago from Sept. 12 to 14. The 11th annual conference combines world-class education, powerful networking, and cutting-edge technology to help rehabilitation therapy professionals enhance their practices.

Key Points: 
  • The 11th annual conference combines world-class education, powerful networking, and cutting-edge technology to help rehabilitation therapy professionals enhance their practices.
  • Known within the industry for its outstanding educational offerings, WebPT is looking for thought-provoking speakers to feature at the leading rehab therapy conference.
  • These proposals should feature engaging and practical content that empowers clinic leaders to efficiently manage their business, enhance profitability, and thrive as rehabilitation therapy experts.
  • This year's theme, Mapping the Future, encourages speakers to explore, envision, and plan for what lies ahead in the industry.

TOM DENNINGER NAMED EXECUTIVE DIRECTOR OF THE INSTITUTE FOR MUSCULOSKELETAL ADVANCEMENT (iMSKA)

Retrieved on: 
Mittwoch, Mai 1, 2024
OCS, Quality, Drug, Innovation, DPT, Human musculoskeletal system, Doctor of Philosophy, Research, Development, Learning, Science, ATI Physical Therapy, MSK, Sacred Heart University, MBA, Growth, Nursing

BOLINGBROOK, Ill., May 1, 2024 /PRNewswire/ -- The Institute for Musculoskeletal Advancement (iMSKA) today appointed Tom Denninger, PT, DPT, OCS, FAAOMPT, as Executive Director. This is the first executive appointment by iMSKA, which announced its formation earlier this year. Mr. Denninger will play a pivotal role in shaping the strategy for equipping, training, and transforming MSK care delivery through research and post professional development.

Key Points: 
  • Founded by ATI Physical Therapy, iMSKA will drive musculoskeletal research and post-secondary education in the field
    BOLINGBROOK, Ill., May 1, 2024 /PRNewswire/ -- The Institute for Musculoskeletal Advancement ( iMSKA ) today appointed Tom Denninger, PT, DPT, OCS, FAAOMPT, as Executive Director.
  • Mr. Denninger will play a pivotal role in shaping the strategy for equipping, training, and transforming MSK care delivery through research and post professional development.
  • "iMSKA represents a commitment to advance scientific MSK research while providing resources and opportunities for practicing professionals," Mr. Denninger said.
  • Previously, Mr. Denninger was Senior Director of Learning and Development ATI Physical Therapy, where he oversaw all internal and external clinical education and development programs.

University of St. Augustine for Health Sciences Fills Healthcare Industry Shortages with New Innovative Programs

Retrieved on: 
Dienstag, April 16, 2024
Accreditation Council, Psychiatric-mental health nurse practitioner, University, Chancellor (education), Autumn, Accreditation, MSN, Outline of health sciences, BSN, Education, SLP, Suite, DPT, USAHS, Employment, Student, Curriculum, Commission, Council, Occupational therapy, Patient, Faculty, Workforce, Anatomical pathology, Speech–language pathology, SAN, MOT, Nursing

These programs aim to prepare students for advanced clinical practice and leadership roles in top healthcare specialties.

Key Points: 
  • These programs aim to prepare students for advanced clinical practice and leadership roles in top healthcare specialties.
  • In the healthcare disciplines that USAHS addresses, practitioner shortages are growing while demand for treatment is increasing; therefore, boosting the educational pipeline has become more critical than ever.
  • Dedicated to graduate studies in health sciences, USAHS fills the healthcare industry pipeline gaps through innovative blended online and hands-on programs, allowing students to live almost anywhere in the U.S. while obtaining their master's or doctorate degrees.
  • They also ensure that the University’s programs prepare graduate students for their future careers and fill the existing healthcare pipeline gaps.

Ekso Bionics Receives Final Payment Determination for Medicare Reimbursement from the Centers for Medicare & Medicaid Services (CMS) for Ekso Indego Personal

Retrieved on: 
Freitag, April 12, 2024
SCI, CMS, Bionics, Data analysis, Rehabilitation, DPT, Ekso Bionics, Life, Patient, Mental health, Medicare, Tetraplegia, Quality of life, Division, NCS, SAN, Health insurance

As previously announced, CMS approved use of Healthcare Common Procedure Coding System Code K1007 to bill Medicare for the Ekso Indego Personal.

Key Points: 
  • As previously announced, CMS approved use of Healthcare Common Procedure Coding System Code K1007 to bill Medicare for the Ekso Indego Personal.
  • This code can also be used by other public health insurance programs as well as private payers.
  • Ekso Bionics will work with inpatient and outpatient clinics across the country to qualify individuals with spinal cord injuries who can potentially benefit from the Ekso Indego Personal.
  • Ekso Bionics has worked with many of these facilities by offering clinical demonstrations, where interested individuals can trial the Ekso Indego Personal.

Net Health Secures Dr. Drew Contreras and Geeta "Dr. G" Nayyar to Speak at First-Ever Rehab Therapy and Wound Care Product Summit

Retrieved on: 
Donnerstag, April 25, 2024
Physical, APTA, The Wall Street Journal, Hospital, Sport, Health, White House Medical Unit, Electronic health record, Innovation, DPT, MD, Conference, Live, Health information management, USA Today, Patient, Nursing, MBA, Organization

PITTSBURGH, April 25, 2024 /PRNewswire/ -- Net Health, a trusted source for specialized software solutions that empower restorative care providers across the continuum of care, today announced that Dr. Drew Contreras, PT, DPT, and Geeta "Dr. G" Nayyar, MD, MBA, will join its inaugural Net Health NEXT Customer Conference on May 9, 2024, in Tampa Bay, Florida. Participants will experience a convergence of innovation, expertise, and industry insights that promises to enhance patient care and operational efficiency in rehab therapy and wound care. Complimentary event registration is open to Net Health customers for a limited time.

Key Points: 
  • Participants will experience a convergence of innovation, expertise, and industry insights that promises to enhance patient care and operational efficiency in rehab therapy and wound care.
  • Complimentary event registration is open to Net Health customers for a limited time.
  • "As the wound care and rehab therapy industries continue to evolve, we must arm providers with the tools and practices necessary to continue delivering world-class care," said Ron Books, CEO of Net Health.
  • The event is set to bring together Net Health customers and wound care and rehab therapy leaders from private practices, hospitals, contract therapy organizations, rehab therapy enterprises, skilled nursing, and assisted living facilities.

Rizing Tide Foundation Unveils New Employer Connect Program

Retrieved on: 
Dienstag, April 16, 2024
U.S, DPT, Culture, Patient, Acquisition, ATC, Tide, Student, Organization, Connect, Lighthouse, Nursing

PHOENIX, April 16, 2024 /PRNewswire/ -- Rizing Tide, a foundation dedicated to creating a more inclusive physical therapy (PT) workforce through its scholarship program supporting racially and ethnically underrepresented students and residents, is proud to announce the launch of a new initiative, the Lighthouse Employer Connect program. Employer Connect was developed to bridge the gap between rehab therapy employers seeking promising job candidates and Rizing Tide's diverse pool of skilled professionals. This program's exclusive job board among other networking and connection opportunities will serve as a crucial step in addressing the labor crisis facing the physical therapy industry.

Key Points: 
  • PHOENIX, April 16, 2024 /PRNewswire/ -- Rizing Tide , a foundation dedicated to creating a more inclusive physical therapy (PT) workforce through its scholarship program supporting racially and ethnically underrepresented students and residents, is proud to announce the launch of a new initiative, the Lighthouse Employer Connect program.
  • Employer Connect was developed to bridge the gap between rehab therapy employers seeking promising job candidates and Rizing Tide's diverse pool of skilled professionals.
  • "We are excited to launch the Employer Connect program and to address the labor crisis facing the physical therapy industry while also championing inclusive workplaces," said Dr. Heidi Jannenga, PT, DPT, ATC , the founder and CEO of Rizing Tide.
  • To date, the following companies have officially partnered with Rizing Tide via the Employer Connect program:

FYZICAL Therapy & Balance Centers Paves Way for Physical Therapists to Achieve Clinic Ownership

Retrieved on: 
Mittwoch, April 10, 2024
Therapy, Patient, Private practice, DPT, Partnership, Bailey, Marketing, PTS, Growth

SARASOTA, Fla., April 10, 2024 /PRNewswire/ -- FYZICAL Therapy & Balance Centers, the country's fastest-growing physical therapy franchise, is officially launching its Partnership Advantage Program, a unique initiative for licensed physical therapists wanting to open their own clinics to partner with seasoned entrepreneurs. This exclusive partnership will allow more physical therapists (PTs) the opportunity to pursue business ownership and contribute to the growth, establishment, and expansion of FYZICAL clinics nationwide.

Key Points: 
  • SARASOTA, Fla., April 10, 2024 /PRNewswire/ -- FYZICAL Therapy & Balance Centers , the country's fastest-growing physical therapy franchise, is officially launching its Partnership Advantage Program , a unique initiative for licensed physical therapists wanting to open their own clinics to partner with seasoned entrepreneurs.
  • This exclusive partnership will allow more physical therapists (PTs) the opportunity to pursue business ownership and contribute to the growth, establishment, and expansion of FYZICAL clinics nationwide.
  • FYZICAL's Partnership Advantage Program is a platform designed to empower licensed PTs, matching them with well-funded entrepreneurs with strong business acumen.
  • The Partnership Advantage Program was inspired by the success story of Chris Bailey, PT, DPT, who owned a private physical therapy clinic outside Erie, Pennsylvania.

ONWARD® Medical Submits De Novo Application to FDA for its ARC-EX® System

Retrieved on: 
Dienstag, April 2, 2024
De novo, DPT, BCI, Arm, Paralysis, Evaluation, Doctor of Philosophy, Quality of life, Euronext, BDD, Annual report, Craig Hospital, Spinal cord, Safety, ARC, Food, Marketing, FDA, SCI, NCS, Movement, Hand, Medical device

EINDHOVEN, the Netherlands, April 02, 2024 (GLOBE NEWSWIRE) -- ONWARD Medical N.V. (Euronext: ONWD), the medical technology company creating innovative spinal cord stimulation therapies to improve or restore movement, function, and independence in people with spinal cord injury (SCI), today announces it has submitted its De Novo application to the US Food and Drug Administration (FDA) to allow marketing of its breakthrough ARC-EX System to restore function of the upper extremities after SCI.

Key Points: 
  • The submission marks an historic milestone for the Company in its mission to restore mobility and function for people with SCI.
  • Once cleared by the FDA, ARC-EX will be the first-ever spinal cord stimulation therapy to restore hand and arm function after SCI and the first commercial product for ONWARD Medical.
  • “We are delighted to be one step closer to bringing our breakthrough ARC-EX System to people living with SCI after submitting this De Novo application for regulatory clearance in the United States,” said ONWARD Medical CEO Dave Marver.
  • The ARC-EX System was previously awarded FDA Breakthrough Device Designation (BDD) for upper limb function, which provided prioritized FDA review, the opportunity to interact with FDA experts, and the potential for additional reimbursement.

Lifecore Biomedical Concludes Strategic Evaluation Process, Announces Management Succession and Board Changes

Retrieved on: 
Mittwoch, März 20, 2024
DPT, CDMO, Growth, Chairperson, Wynnefield Capital, University, Laboratory, Head, Senior, Marketing, Syringe, Investment, Annual report, Retirement, Calendar, Corporate development, Fiscal, Management

CHASKA, Minn., March 20, 2024 (GLOBE NEWSWIRE) -- Lifecore Biomedical, Inc. (NASDAQ: LFCR) (“Lifecore” or the “Company”), a fully integrated contract development and manufacturing organization (“CDMO”), today announced that its Board of Directors unanimously approved the conclusion of its review of strategic alternatives that was initiated in March 2023, and, concurrently therewith, announced several strategic updates related to its operations on a stand-alone basis.

Key Points: 
  • This conclusion was based on an expansive strategic review process, including outreach to and engagement with over 75 buyers, including both strategic buyers and financial sponsors.
  • “The Board of Directors appreciates all of the hard work put into the strategic review process by the Company and its advisors.
  • The Board looks forward to working with the management team to lead the Company’s execution on its strategic plan,” said Craig Barbarosh, Chairman of the Board.
  • With these investments, Lifecore believes it is positioned for substantial growth as its additional aseptic capacity becomes available.